{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:52:07Z","timestamp":1792792327989,"version":"4.5.0"},"reference-count":112,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Epidemiological evidence continues to accumulate on the effect of stress and depression on cancer initiation and progression. Depression has been introduced as an independent predictor of increased cancer mortality. At the same time, early intervention for depression increases the surviv-al rate. Even some evidence has given prognostic value for depression to predict cancer recurrence and mortality. This article presents current evidence on the correlations of molecular mechanisms of cancer and depression through; I. The evidence shows the role of pre-existing depression and anxie-ty in the development and progression of cancer. II. The Immune system performs a crucial role in stress, depression, and cancer. III. The role of stress and depression-induced inflammation. IV. The evidence has proposed that cancer may result in depression and the effect of depression on cancer outcomes. In conclusion, the importance of preventive interventions to monitor patients\u2019 mental health during cancer treatment is very significant and should not be underestimated. In other words, the initial interventions can improve depressive symptoms and increase cancer survival. On the oth-er hand, by identifying key biomarkers of depression, physicians can identify cancer patients at risk for depression or those who may not respond to routine treatments. Revealing the molecular mecha-nism of the cancer microenvironment in the development of comorbidities promises innovative therapeutic options for cancer. Identifying these mechanisms opens a new avenue in identifying cancer patients at risk for depression and can also provide considerable potential in identifying de-pressive patients prone to cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220922094403","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:29:43Z","timestamp":1663907383000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bidirectional Relations Between Anxiety, Depression, and Cancer: A Review"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5010-7293","authenticated-orcid":true,"given":"Soheila","family":"Montazersaheb","sequence":"first","affiliation":[{"name":"Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiedeh Razi","family":"Soofiyani","sequence":"first","affiliation":[{"name":"Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailar","family":"Nakhlband","sequence":"additional","affiliation":[{"name":"Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheleh","family":"Farahzadi","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazli","family":"Saeedi","sequence":"additional","affiliation":[{"name":"Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibeh","family":"Barzegar","sequence":"additional","affiliation":[{"name":"Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4306\/pi.2017.14.5.618","volume":"14","author":"Park B.","year":"2017","unstructured":"Park B.; Youn S.; Yi K.K.; Lee S.; Lee J.S.; Chung S.; The prevalence of depression among patients with the top ten most common cancers in South Korea. Psychiatry Investig 2017,14(5),618-625","journal-title":"Psychiatry Investig"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/npp.2015.266","volume":"41","author":"Smoller J.W.","year":"2016","unstructured":"Smoller J.W.; The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology 2016,41(1),297-319","journal-title":"Neuropsychopharmacology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/appi.ajp.2013.13030325","volume":"171","author":"Cuijpers P.","year":"2014","unstructured":"Cuijpers P.; Vogelzangs N.; Twisk J.; Kleiboer A.; Li J.; Penninx B.W.; Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry 2014,171(4),453-462","journal-title":"Am J Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jad.2008.04.002","volume":"113","author":"Lloyd-Williams M.","year":"2009","unstructured":"Lloyd-Williams M.; Shiels C.; Taylor F.; Dennis M.; Depression - An independent predictor of early death in patients with advanced cancer. J Affect Disord 2009,113(1-2),127-132","journal-title":"J Affect Disord"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","volume":"25","author":"Wang X.","year":"2020","unstructured":"Wang X.; Wang N.; Zhong L.; Prognostic value of depression and anxiety on breast cancer recurrence and mortality: A systematic review and meta-analysis of 282,203 patients. Mol Psychiatry 2020,25(12),3186-3197","journal-title":"Mol Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1002\/hed.26868","volume":"43","author":"Van der Elst S.","year":"2021","unstructured":"Van der Elst S.; Bardash Y.; Wotman M.; Kraus D.; Tham T.; The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta\u2010analysis. Head Neck 2021,43(11),3608-3617","journal-title":"Head Neck"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"345(jul31 4): e4933","DOI":"10.1136\/bmj.e4933","author":"Russ TC","year":"2012","unstructured":"Russ TC; Stamatakis E; Hamer M; Starr JM; Kivim&#xE4;ki M; Batty GD; Association between psychological distress and mortality: Individual participant pooled analysis of 10 prospective cohort studies. BMJ 2012,345(jul31 4): e4933"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamapsychiatry.2019.0998","volume":"76","author":"Domschke K.","year":"2019","unstructured":"Domschke K.; Gottschalk M.G.; Genetics of anxiety and stress-related disorders-toward a bottom-up cross-disorder psychopathology. JAMA Psychiatry 2019,76(9),889-890","journal-title":"JAMA Psychiatry"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-061212-171507","volume":"65","author":"Currier M.B.","year":"2014","unstructured":"Currier M.B.; Nemeroff C.B.; Depression as a risk factor for cancer: From pathophysiological advances to treatment implications. Annu Rev Med 2014,65(1),203-221","journal-title":"Annu Rev Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.puhe.2017.04.026","volume":"149","author":"Jia Y.","year":"2017","unstructured":"Jia Y.; Li F.; Liu Y.F.; Zhao J.P.; Leng M.M.; Chen L.; Depression and cancer risk: A systematic review and meta-analysis. Public Health 2017,149,138-148","journal-title":"Public Health"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/ncponc1134","volume":"5","author":"Chida Y.","year":"2008","unstructured":"Chida Y.; Hamer M.; Wardle J.; Steptoe A.; Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008,5(8),466-475","journal-title":"Nat Clin Pract Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"100207","DOI":"10.1016\/j.imu.2019.100207","volume":"16","author":"Rahman M.R.","year":"2019","unstructured":"Rahman M.R.; Islam T.; Al-Mamun M.A.; Zaman T.; Karim M.R.; Moni M.A.; The influence of depression on ovarian cancer: Discovering molecular pathways that identify novel biomarkers and therapeutic targets. Informatics in Medicine Unlocked 2019,16,100207","journal-title":"Informatics in Medicine Unlocked"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbi.2020.11.005","volume":"93","author":"Cui B.","year":"2021","unstructured":"Cui B.; Peng F.; Lu J.; Cancer and stress: NextGen strategies. Brain Behav Immun 2021,93,368-383","journal-title":"Brain Behav Immun"},{"key":"ref=14","author":"Niknamian S.","year":"2019","unstructured":"Niknamian S.;  The impact of stress 2019","journal-title":"The impact of stress"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cobeha.2019.01.008","volume":"28","author":"Cole S.W.","year":"2019","unstructured":"Cole S.W.; The Conserved transcriptional response to adversity. Curr Opin Behav Sci 2019,28,31-37","journal-title":"Curr Opin Behav Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-3083.1982.tb00618.x","volume":"15","author":"Palacios R.","year":"1982","unstructured":"Palacios R.; Sugawara I.; Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor. Scand J Immunol 1982,15(1),25-31","journal-title":"Scand J Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/cncr.31943","volume":"125","author":"Antoni M.H.","year":"2019","unstructured":"Antoni M.H.; Dhabhar F.S.; The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer 2019,125(9),1417-1431","journal-title":"Cancer"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","volume":"63","author":"Pavlov V.A.","year":"2015","unstructured":"Pavlov V.A.; Tracey K.J.; Neural circuitry and immunity. Immunol Res 2015,63(1-3),38-57","journal-title":"Immunol Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2174\/1381612822666161025152942","volume":"23","author":"Xu Z.","year":"2017","unstructured":"Xu Z.; Shioda S.; Masahisa J.; Role of the autonomic nervous system in the tumor micro-environment and its therapeutic potential. Curr Pharm Des 2017,23(11),1687-1692","journal-title":"Curr Pharm Des"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cmet.2016.01.015","volume":"23","author":"Nagaraja A.S.","year":"2016","unstructured":"Nagaraja A.S.; Sadaoui N.C.; Dorniak P.L.; Lutgendorf S.K.; Sood A.K.; SnapShot: Stress and disease. Cell Metab 2016,23(2),388","journal-title":"Cell Metab"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"Miller A.H.","year":"2009","unstructured":"Miller A.H.; Maletic V.; Raison C.L.; Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009,65(9),732-741","journal-title":"Biol Psychiatry"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","volume":"52","author":"Bortolato B.","year":"2017","unstructured":"Bortolato B.; Hyphantis T.N.; Valpione S.; Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat Rev 2017,52,58-70","journal-title":"Cancer Treat Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes M.","year":"2011","unstructured":"Maes M.; Leonard B.E.; Myint A.M.; Kubera M.; Verkerk R.; The new \u20185-HT\u2019 hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011,35(3),702-721","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pnpbp.2012.10.006","volume":"48","author":"Sperner-Unterweger B.","year":"2014","unstructured":"Sperner-Unterweger B.; Kohl C.; Fuchs D.; Immune changes and neurotransmitters: Possible interactions in depression? Prog Neuropsychopharmacol Biol Psychiatry 2014,48,268-276","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"113485","DOI":"10.1016\/j.expneurol.2020.113485","volume":"334","author":"Pierone B.C.","year":"2020","unstructured":"Pierone B.C.; Pereira C.A.; Garcez M.L.; Kaster M.P.; Stress and signaling pathways regulating autophagy: From behavioral models to psychiatric disorders. Exp Neurol 2020,334,113485","journal-title":"Exp Neurol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000319504","author":"Leonard B.E.","year":"2010","unstructured":"Leonard B.E.;  The concept of depression as a dysfunction of the immune system Depression: From psychopathology to pharmacotherapy 27 2010,53-71","journal-title":"The concept of depression as a dysfunction of the immune system Depression: From psychopathology to pharmacotherapy 27"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/icb.2011.112","volume":"90","author":"Hasnain S.Z.","year":"2012","unstructured":"Hasnain S.Z.; Lourie R.; Das I.; Chen A.C.H.; McGuckin M.A.; The interplay between endoplasmic reticulum stress and inflammation. Immunol Cell Biol 2012,90(3),260-270","journal-title":"Immunol Cell Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12026-014-8517-0","volume":"58","author":"Dhabhar F.S.","year":"2014","unstructured":"Dhabhar F.S.; Effects of stress on immune function: The good, the bad, and the beautiful. Immunol Res 2014,58(2-3),193-210","journal-title":"Immunol Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41419-019-2030-2","volume":"10","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Zhang Y.; He Z.; Chronic stress promotes gastric cancer progression and metastasis: An essential role for ADRB2. Cell Death Dis 2019,10(11),788","journal-title":"Cell Death Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","volume":"75","author":"Jobling P.","year":"2015","unstructured":"Jobling P.; Pundavela J.; Oliveira S.M.R.; Roselli S.; Walker M.M.; Hondermarck H.; Nerve\u2013cancer cell crosstalk: A novel promoter of tumor progression. Cancer Res 2015,75(9),1777-1781","journal-title":"Cancer Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1037\/a0035302","volume":"140","author":"Slavich G.M.","year":"2014","unstructured":"Slavich G.M.; Irwin M.R.; From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull 2014,140(3),774-815","journal-title":"Psychol Bull"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/10253890500100240","volume":"8","author":"Bauer M.E.","year":"2005","unstructured":"Bauer M.E.; Stress, glucocorticoids and ageing of the immune system. Stress 2005,8(1),69-83","journal-title":"Stress"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0022-4731(87)90359-1","volume":"27","author":"De Nicola A.F.","year":"1987","unstructured":"De Nicola A.F.; Ort&#xED; E.; Moses D.F.; Magari&#xF1;os A.M.; Coirini H.; Functions and dysfunctions of receptors for adrenal corticoids in the central nervous system. J Steroid Biochem 1987,27(1-3),599-607","journal-title":"J Steroid Biochem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11481-006-9036-0","volume":"1","author":"Godbout J.P.","year":"2006","unstructured":"Godbout J.P.; Glaser R.; Stress-induced immune dysregulation: Implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol 2006,1(4),421-427","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"105586","DOI":"10.1016\/j.phrs.2021.105586","volume":"168","author":"Tang M.","year":"2021","unstructured":"Tang M.; Liu T.; Jiang P.; Dang R.; The interaction between autophagy and neuroinflammation in major depressive disorder: From pathophysiology to therapeutic implications. Pharmacol Res 2021,168,105586","journal-title":"Pharmacol Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","volume":"105","author":"Maier S.F.","year":"1998","unstructured":"Maier S.F.; Watkins L.R.; Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998,105(1),83-107","journal-title":"Psychol Rev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000087104","volume":"12","author":"Elenkov I.J.","year":"2005","unstructured":"Elenkov I.J.; Iezzoni D.G.; Daly A.; Harris A.G.; Chrousos G.P.; Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005,12(5),255-269","journal-title":"Neuroimmunomodulation"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000079408","volume":"11","author":"Lee B.N.","year":"2004","unstructured":"Lee B.N.; Dantzer R.; Langley K.E.; A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 2004,11(5),279-292","journal-title":"Neuroimmunomodulation"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/08880018.2018.1440335","volume":"35","author":"Narendran G.","year":"2018","unstructured":"Narendran G.; Tomfohr L.; Schulte F.; Inflammatory cytokines and depression in children with cancer: A review of the literature. Pediatr Hematol Oncol 2018,35(1),11-19","journal-title":"Pediatr Hematol Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/pon.4316","volume":"26","author":"Li M.","year":"2017","unstructured":"Li M.; Kouzmina E.; McCusker M.; Pro- and anti-inflammatory cytokine associations with major depression in cancer patients. Psychooncology 2017,26(12),2149-2156","journal-title":"Psychooncology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fpsyt.2018.00299","volume":"9","author":"Young K.","year":"2018","unstructured":"Young K.; Singh G.; Biological mechanisms of cancer-induced depression. Front Psychiatry 2018,9,299","journal-title":"Front Psychiatry"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/ol.2015.2944","volume":"9","author":"Smith H.R.","year":"2015","unstructured":"Smith H.R.; Depression in cancer patients: Pathogenesis, implications and treatment. (Review). Oncol Lett 2015,9(4),1509-1514","journal-title":"Oncol Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MCO.0b013e328340d849","volume":"14","author":"Kurz K.","year":"2011","unstructured":"Kurz K.; Schroecksnadel S.; Weiss G.; Fuchs D.; Association between increased tryptophan degradation and depression in cancer patients. Curr Opin Clin Nutr Metab Care 2011,14(1),49-56","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"29(2 and 3): 165-80","DOI":"10.1097\/FBP.0000000000000384","author":"Barreto FS","year":"2018","unstructured":"Barreto FS; Chaves Filho AJM; de Ara&#xFA;jo MCCR; Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer. Behav Pharmacol 2018,29(2 and 3): 165-80"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3389\/fpsyg.2017.01561","volume":"8","author":"Hestad K.A.","year":"2017","unstructured":"Hestad K.A.; Engedal K.; Whist J.E.; Farup P.G.; The relationships among tryptophan, kynurenine, indoleamine 2, 3-dioxygenase, depression, and neuropsychological performance. Front Psychol 2017,8,1561","journal-title":"Front Psychol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"eabf4905","DOI":"10.1126\/sciimmunol.abf4905","volume":"5","author":"Yin X.","year":"2020","unstructured":"Yin X.; Eisenbarth S.C.; Torn between type 1 and type 2 immunity. Sci Immunol 2020,5(53),eabf4905","journal-title":"Sci Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","volume":"35","author":"Maes M.","year":"2011","unstructured":"Maes M.; Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011,35(3),664-675","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-030-10811-3_3","author":"Broere F.","year":"2019","unstructured":"Broere F.; Eden Wv.;  T cell subsets and T cell-mediated immunity Nijkamp and Parnham\u2019s Principles of Immunopharmacology 2019,23-35","journal-title":"T cell subsets and T cell-mediated immunity Nijkamp and Parnham\u2019s Principles of Immunopharmacology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuroscience.2022.05.014","volume":"498","author":"Jiang G.","year":"2022","unstructured":"Jiang G.; Wang Y.; Liu Q.; Autophagy: A new mechanism for esketamine as a depression therapeutic. Neuroscience 2022,498,214-223","journal-title":"Neuroscience"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.coph.2021.07.013","volume":"60","author":"Sumitomo A.","year":"2021","unstructured":"Sumitomo A.; Tomoda T.; Autophagy in neuronal physiology and disease. Curr Opin Pharmacol 2021,60,133-140","journal-title":"Curr Opin Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"Glick D.","year":"2010","unstructured":"Glick D.; Barth S.; Macleod K.F.; Autophagy: Cellular and molecular mechanisms. J Pathol 2010,221(1),3-12","journal-title":"J Pathol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-biochem-061516-044820","volume":"86","author":"Hurley J.H.","year":"2017","unstructured":"Hurley J.H.; Young L.N.; Mechanisms of autophagy initiation. Annu Rev Biochem 2017,86(1),225-244","journal-title":"Annu Rev Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12264-015-1548-2","volume":"31","author":"Jia J.","year":"2015","unstructured":"Jia J.; Le W.; Molecular network of neuronal autophagy in the pathophysiology and treatment of depression. Neurosci Bull 2015,31(4),427-434","journal-title":"Neurosci Bull"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuint.2018.01.004","volume":"114","author":"Xiao X.","year":"2018","unstructured":"Xiao X.; Shang X.; Zhai B.; Zhang H.; Zhang T.; Nicotine alleviates chronic stress-induced anxiety and depressive-like behavior and hippocampal neuropathology via regulating autophagy signaling. Neurochem Int 2018,114,58-70","journal-title":"Neurochem Int"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/cns.12755","volume":"23","author":"Alcocer-G&#xF3;mez E.","year":"2017","unstructured":"Alcocer-G&#xF3;mez E.; Casas-Barquero N.; N&#xFA;&#xF1;ez-Vasco J.; Navarro-Pando J.M.; Bull&#xF3;n P.; Psychological status in depressive patients correlates with metabolic gene expression. CNS Neurosci Ther 2017,23(10),843-845","journal-title":"CNS Neurosci Ther"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fpsyt.2019.00337","volume":"10","author":"Gassen N.C.","year":"2019","unstructured":"Gassen N.C.; Rein T.; Is there a role of autophagy in depression and antidepressant action? Front Psychiatry 2019,10,337","journal-title":"Front Psychiatry"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.31.445775","author":"H&#xE4;usl A.S.","year":"2021","unstructured":"H&#xE4;usl A.S.; Brix L.M.; Bajaj T.; Mediobasal hypothalamic FKBP51 acts as a molecular switch linking autophagy to whole-body metabolism. bioRxiv 2021","journal-title":"bioRxiv"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/15548627.2015.1017224","volume":"11","author":"Gassen N.C.","year":"2015","unstructured":"Gassen N.C.; Hartmann J.; Schmidt M.V.; Rein T.; FKBP5\/FKBP51 enhances autophagy to synergize with antidepressant action. Autophagy 2015,11(3),578-580","journal-title":"Autophagy"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e1001755","DOI":"10.1371\/journal.pmed.1001755","volume":"11","author":"Gassen N.C.","year":"2014","unstructured":"Gassen N.C.; Hartmann J.; Zschocke J.; Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: Evidence in cells, mice, and humans. PLoS Med 2014,11(11),e1001755","journal-title":"PLoS Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"k1415","DOI":"10.1136\/bmj.k1415","volume":"361","author":"Pitman A.","year":"2018","unstructured":"Pitman A.; Suleman S.; Hyde N.; Hodgkiss A.; Depression and anxiety in patients with cancer. BMJ 2018,361,k1415","journal-title":"BMJ"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1002\/cncr.24561","volume":"115","author":"Satin J.R.","year":"2009","unstructured":"Satin J.R.; Linden W.; Phillips M.J.; Depression as a predictor of disease progression and mortality in cancer patients. Cancer 2009,115(22),5349-5361","journal-title":"Cancer"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0006-3223(03)00566-3","volume":"54","author":"Spiegel D.","year":"2003","unstructured":"Spiegel D.; Giese-Davis J.; Depression and cancer: Mechanisms and disease progression. Biol Psychiatry 2003,54(3),269-282","journal-title":"Biol Psychiatry"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1017\/S0033291709992285","volume":"40","author":"Pinquart M.","year":"2010","unstructured":"Pinquart M.; Duberstein P.R.; Depression and cancer mortality: A meta-analysis. Psychol Med 2010,40(11),1797-1810","journal-title":"Psychol Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.04.010","volume":"49","author":"Schrepf A.","year":"2015","unstructured":"Schrepf A.; Lutgendorf S.K.; Pyter L.M.; Pre-treatment effects of peripheral tumors on brain and behavior: Neuroinflammatory mechanisms in humans and rodents. Brain Behav Immun 2015,49,1-17","journal-title":"Brain Behav Immun"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.genhosppsych.2016.10.002","volume":"44","author":"Antoni M.H.","year":"2017","unstructured":"Antoni M.H.; Jacobs J.M.; Bouchard L.C.; Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up. Gen Hosp Psychiatry 2017,44,16-21","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1200\/JCO.2010.28.4455","volume":"29","author":"Giese-Davis J.","year":"2011","unstructured":"Giese-Davis J.; Collie K.; Rancourt K.M.S.; Neri E.; Kraemer H.C.; Spiegel D.; Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: A secondary analysis. J Clin Oncol 2011,29(4),413-420","journal-title":"J Clin Oncol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.genhosppsych.2007.10.008","volume":"30","author":"Fann J.R.","year":"2008","unstructured":"Fann J.R.; Thomas-Rich A.M.; Katon W.J.; Major depression after breast cancer: A review of epidemiology and treatment. Gen Hosp Psychiatry 2008,30(2),112-126","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000367913","volume":"84","author":"Cosci F.","year":"2015","unstructured":"Cosci F.; Fava G.A.; Sonino N.; Mood and anxiety disorders as early manifestations of medical illness: A systematic review. Psychother Psychosom 2015,84(1),22-29","journal-title":"Psychother Psychosom"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jad.2011.09.012","volume":"136","author":"Van Esch L.","year":"2012","unstructured":"Van Esch L.; Roukema J.A.; Ernst M.F.; Nieuwenhuijzen G.A.P.; De Vries J.; Combined anxiety and depressive symptoms before diagnosis of breast cancer. J Affect Disord 2012,136(3),895-901","journal-title":"J Affect Disord"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1002\/cncr.25318","volume":"116","author":"Schneider S.","year":"2010","unstructured":"Schneider S.; Moyer A.; Depression as a predictor of disease progression and mortality in cancer patients. Cancer 2010,116(13),3304","journal-title":"Cancer"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejphar.2007.11.071","volume":"583","author":"McEwen B.S.","year":"2008","unstructured":"McEwen B.S.; Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008,583(2-3),174-185","journal-title":"Eur J Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/oxfordjournals.aje.a115087","volume":"128","author":"Farmer M.","year":"1988","unstructured":"Farmer M.; Locke B.Z.; Mo&#x15B;cicki EK, Dannenberg AL, Larson DB, Radloff LS. Physical activity and depressive symptoms: The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1988,128(6),1340-1351","journal-title":"Am J Epidemiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S0140-6736(00)02821-X","volume":"356","author":"Colleoni M.","year":"2000","unstructured":"Colleoni M.; Mandala M.; Peruzzotti G.; Robertson C.; Bredart A.; Goldhirsch A.; Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000,356(9238),1326-1327","journal-title":"Lancet"},{"key":"ref=74","first-page":"150","volume":"12","author":"Vlad-Andrei D.","year":"2020","unstructured":"Vlad-Andrei D.; Enache R-G.; Depression in cancer patients. Technium Soc Sci J 2020,12,150","journal-title":"Technium Soc Sci J"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.36437\/irmhs.2019.2.1.J","volume":"2","author":"Madmoli M.","year":"2019","unstructured":"Madmoli M.; A systematic review study on the changer factors of the quality of life in cancer patients. Int Res Med Health Sci 2019,2(1),8-15","journal-title":"Int Res Med Health Sci"},{"key":"ref=76","first-page":"62","volume":"33","author":"Ahmed E.","year":"2019","unstructured":"Ahmed E.; Antidepressants in patients with advanced cancer: When They\u2019re warranted and how to choose therapy. Oncology (Williston Park) 2019,33(2),62-68","journal-title":"Oncology (Williston Park)"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-642-40134-3_9","author":"Fitzgerald P.","year":"2014","unstructured":"Fitzgerald P.; Li M.; Grassi L.; Rodin G.;  Pharmacotherapy of depression in cancer patients Psychopharmacology in Oncology and Palliative Care 2014,145-161","journal-title":"Pharmacotherapy of depression in cancer patients Psychopharmacology in Oncology and Palliative Care"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.9740\/mhc.n194575","volume":"4","author":"Baltenberger E.P.","year":"2014","unstructured":"Baltenberger E.P.; Schmitt G.; Thomas C.J.; Treatment of depressive symptoms in patients with cancer. Ment Health Clin 2014,4(3),114-117","journal-title":"Ment Health Clin"},{"key":"ref=79","first-page":"286","volume":"2","author":"Lu D-Y.","year":"2018","unstructured":"Lu D-Y.; Lu T.; Che J.; Yarla N.; Individualized cancer therapy, what is the next generation. EC Cancer 2018,2(6),286-297","journal-title":"EC Cancer"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1634\/theoncologist.2018-0096","volume":"24","author":"Wong R.L.","year":"2019","unstructured":"Wong R.L.; El-Jawahri A.; D\u2019Arpino S.M.; Use of antidepressant medications moderates the relationship between depressive symptoms and hospital length of stay in patients with advanced cancer. Oncologist 2019,24(1),117-124","journal-title":"Oncologist"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/TPSY.TPSY_3_19","volume":"33","author":"Shen W.W.","year":"2019","unstructured":"Shen W.W.; Chang S-C.; Antidepressant therapy in patients with cancer: A clinical review. Taiwanese Journal of Psychiatry 2019,33(1),13","journal-title":"Taiwanese Journal of Psychiatry"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ctrv.2015.06.003","volume":"41","author":"Ostuzzi G.","year":"2015","unstructured":"Ostuzzi G.; Benda L.; Costa E.; Barbui C.; Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis. Cancer Treat Rev 2015,41(8),714-724","journal-title":"Cancer Treat Rev"},{"key":"ref=83","first-page":"4(2): e0402195-e","author":"Matiiash T","year":"2019","unstructured":"Matiiash T; Bondarchuk A;  Usage of antidepressants in cancer patients Psychosomatic Medicine and General Practice 2019,4(2): e0402195-e","journal-title":"Usage of antidepressants in cancer patients Psychosomatic Medicine and General Practice"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"Smith E.M.L.","year":"2013","unstructured":"Smith E.M.L.; Pang H.; Cirrincione C.; Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial. JAMA 2013,309(13),1359-1367","journal-title":"JAMA"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/annonc\/mdr045","volume":"23","author":"Durand J.P.","year":"2012","unstructured":"Durand J.P.; Deplanque G.; Montheil V.; Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: Results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 2012,23(1),200-205","journal-title":"Ann Oncol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13643-015-0099-y","volume":"4","author":"Hutton B.","year":"2015","unstructured":"Hutton B.; Yazdi F.; Bordeleau L.; Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: Protocol for a systematic review incorporating network meta-analyses. Syst Rev 2015,4(1),114","journal-title":"Syst Rev"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"e12484","DOI":"10.1111\/ecc.12484","volume":"27","author":"Biglia N.","year":"2018","unstructured":"Biglia N.; Bounous V.E.; Susini T.; Duloxetine and escitalopram for hot flushes: Efficacy and compliance in breast cancer survivors. Eur J Cancer Care (Engl) 2018,27(1),e12484","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11864-020-0704-8","volume":"21","author":"Navari R.M.","year":"2020","unstructured":"Navari R.M.; Nausea and vomiting in advanced cancer. Curr Treat Options Oncol 2020,21(2),14","journal-title":"Curr Treat Options Oncol"},{"key":"ref=89","first-page":"143","volume":"39","author":"Shibahara H.","year":"2012","unstructured":"Shibahara H.; Ito T.; Uematsu N.; Imai E.; Nishimura D.; Low-dose mirtazapine improved nausea and appetite loss during S-1 therapy Gan To Kagaku Ryoho 2012,39(1),143-145","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2174\/1389201017666161018123311","volume":"17","author":"Ming-Hua C.","year":"2016","unstructured":"Ming-Hua C.; Bao-Hua Z.; Lei Y.; Mechanisms of anorexia cancer cachexia syndrome and potential benefits of traditional medicine and natural herbs. Curr Pharm Biotechnol 2016,17(13),1147-1152","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15640\/ijn.v7n2a2","volume":"7","author":"Mangoulia P.","year":"2020","unstructured":"Mangoulia P.; The psychopharmacological management of depression in patients with cancer. Int J Nurs (N Y) 2020,7(2),6-12","journal-title":"Int J Nurs (N Y)"},{"key":"ref=92","first-page":"916","volume":"13","author":"Mohandas H.","year":"2017","unstructured":"Mohandas H.; Jaganathan S.K.; Mani M.P.; Ayyar M.; Rohini Thevi G.V.; Cancer-related fatigue treatment: An overview. J Cancer Res Ther 2017,13(6),916-929","journal-title":"J Cancer Res Ther"},{"key":"ref=93","first-page":"1547","volume":"19","author":"Ashrafi F.","year":"2018","unstructured":"Ashrafi F.; Mousavi S.; Karimi M.; Potential role of bupropion sustained release for cancer-related fatigue: A double-blind, placebo-controlled study. Asian Pacific Journal of Cancer Prevention. APJCP 2018,19(6),1547-1551","journal-title":"APJCP"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"e38886","DOI":"10.1371\/journal.pone.0038886","volume":"7","author":"Fang C.K.","year":"2012","unstructured":"Fang C.K.; Chen H.W.; Chiang I.T.; Mirtazapine inhibits tumor growth via immune response and serotonergic system. PLoS One 2012,7(7),e38886","journal-title":"PLoS One"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.intimp.2015.06.031","volume":"28","author":"Park E.J.","year":"2015","unstructured":"Park E.J.; Lee J.H.; Jeong D.C.; Han S.I.; Jeon Y.W.; Natural killer cell activity in patients with major depressive disorder treated with escitalopram. Int Immunopharmacol 2015,28(1),409-413","journal-title":"Int Immunopharmacol"},{"key":"ref=96","first-page":"4966","volume":"21","author":"Dai J.","year":"2017","unstructured":"Dai J.; Liao N.; Shi J.; Tao J.Q.; Study of prevalence and influencing factors of depression in tumor patients and the therapeutic effects of fluoxetine. Eur Rev Med Pharmacol Sci 2017,21(21),4966-4974","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","volume":"21","author":"Kubera M.","year":"2001","unstructured":"Kubera M.; Lin A.H.; Kenis G.; Bosmans E.; van Bockstaele D.; Maes M.; Anti-Inflammatory effects of antidepressants through suppression of the interferon-&#x3B3;\/interleukin-10 production ratio. J Clin Psychopharmacol 2001,21(2),199-206","journal-title":"J Clin Psychopharmacol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/(SICI)1099-0461(1999)13:6<338:AID-JBT8>3.0.CO;2-7","volume":"13","author":"Xia Z.","year":"1999","unstructured":"Xia Z.; Bergstrand A.; DePierre J.W.; N&#xE4;ssberger L.; The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol 1999,13(6),338-347","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejphar.2015.06.007","volume":"761","author":"Yuan S.Y.","year":"2015","unstructured":"Yuan S.Y.; Cheng C.L.; Ho H.C.; Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo. Eur J Pharmacol 2015,761,309-320","journal-title":"Eur J Pharmacol"},{"key":"ref=100","first-page":"17(11): 1570-7","author":"Ahmadian E","year":"2017","unstructured":"Ahmadian E; Eftekhari A; Babaei H, M; Nayebi A, A; Eghbal M; Anti-cancer effects of citalopram on hepatocellular carcinoma cells occur via cytochrome C release and the activation of NF-kB. Anti- Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2017,17(11): 1570-7"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-981-15-7586-0_9","author":"Atale N.","year":"2020","unstructured":"Atale N.; Rani V.;  Angiogenesis: A Therapeutic Target for Cancer Drug Targets in Cellular Processes of Cancer: From nonclinical to preclinical models 2020,165-183","journal-title":"Angiogenesis: A Therapeutic Target for Cancer Drug Targets in Cellular Processes of Cancer: From nonclinical to preclinical models"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"e50043","DOI":"10.1371\/journal.pone.0050043","volume":"7","author":"Kannen V.","year":"2012","unstructured":"Kannen V.; Hintzsche H.; Zanette D.L.; Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model. PLoS One 2012,7(11),e50043","journal-title":"PLoS One"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4161\/cbt.7.10.6664","volume":"7","author":"Stepulak A.","year":"2008","unstructured":"Stepulak A.; Rzeski W.; Sifringer M.; Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther 2008,7(10),1685-1693","journal-title":"Cancer Biol Ther"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Dowlati Y.","year":"2010","unstructured":"Dowlati Y.; Herrmann N.; Swardfager W.; A meta-analysis of cytokines in major depression. Biol Psychiatry 2010,67(5),446-457","journal-title":"Biol Psychiatry"},{"key":"ref=105","author":"Derhagopian R.","year":"2016","unstructured":"Derhagopian R.;  Postsurgical depressive symptoms and proinflammatory cytokine elevations in women undergoing primary treatment for breast cancer 2016","journal-title":"Postsurgical depressive symptoms and proinflammatory cytokine elevations in women undergoing primary treatment for breast cancer"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"Raison C.L.","year":"2013","unstructured":"Raison C.L.; Rutherford R.E.; Woolwine B.J.; A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry 2013,70(1),31-41","journal-title":"JAMA Psychiatry"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000447034","volume":"85","author":"Carvalho A.F.","year":"2016","unstructured":"Carvalho A.F.; Sharma M.S.; Brunoni A.R.; Vieta E.; Fava G.A.; The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature. Psychother Psychosom 2016,85(5),270-288","journal-title":"Psychother Psychosom"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.bjc.6600013","volume":"86","author":"Sharpe C.R.","year":"2002","unstructured":"Sharpe C.R.; Collet J-P.; Belzile E.; Hanley J.A.; Boivin J-F.; The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer 2002,86(1),92-97","journal-title":"Br J Cancer"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/EDE.0b013e318176bf98","volume":"19","author":"Dalton S.O.","year":"2008","unstructured":"Dalton S.O.; Poulsen A.H.; N&#xF8;rgaard M.; McLaughlin J.K.; Johansen C.; Friis S.; Tricyclic antidepressants and non-Hodgkin lymphoma. Epidemiology 2008,19(4),546-549","journal-title":"Epidemiology"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/aje\/kwi301","volume":"162","author":"Coogan P.F.","year":"2005","unstructured":"Coogan P.F.; Palmer J.R.; Strom B.L.; Rosenberg L.; Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 2005,162(9),835-838","journal-title":"Am J Epidemiol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/aje\/kwh234","volume":"160","author":"Bahl S.","year":"2004","unstructured":"Bahl S.; Cotterchio M.; Kreiger N.; Klar N.; Antidepressant medication use and non-Hodgkin\u2019s lymphoma risk: No association. Am J Epidemiol 2004,160(6),566-575","journal-title":"Am J Epidemiol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/138920011795713706","volume":"12","author":"Caraci F.","year":"2011","unstructured":"Caraci F.; Crupi R.; Drago F.; Spina E.; Metabolic drug interactions between antidepressants and anticancer drugs: Focus on selective serotonin reuptake inhibitors and hypericum extract. Curr Drug Metab 2011,12(6),570-577","journal-title":"Curr Drug Metab"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220922094403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209054\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220922094403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:41:35Z","timestamp":1680151295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209054\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220922094403","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}